Pharmaceutical company’s new £7m facility is a solution for growth

Upperton Pharma Solutions has taken a £7m leap forward with the launch of its new sterile manufacturing facility in Nottingham.

Adding to its existing 50,000 sq ft Trent Gateway site, the purpose-built 7,000 sq ft space is set to handle small-volume liquids and powders for parenteral, nasal and pulmonary delivery, designed to meet the latest EU GMP Annex-1 regulations.

With the capacity to churn out up to 2,000 vials, pre-filled syringes, or cartridges per batch, the facility will tackle everything from formulation development to clinical manufacturing and analytical testing.

Nikki Whitfield, chief executive officer, said: “We are delighted to complete the build of our sterile facility. The combined experience of our leadership team in sterile facility builds and subsequent operations ensure that we are ideally placed as a CDMO partner of choice for small to mid-sized biotech and pharma looking to get into the clinic quickly with fast access to sterile manufacturing services.”

Jon Austwick, director of Quality & Compliance said: “This expansion illustrates our continued investment in our capabilities to support drug developers to scale and accelerate the path to delivering safe and effective medicines to patients. The facility has been built with the highest level of quality and is a testament to our internal teams and build vendors who have worked tirelessly over the past 12 months to bring our vision to life.”